85
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA Lung study

, , , , , , & show all
Pages 207-213 | Received 14 Jan 2014, Accepted 17 Feb 2014, Published online: 21 Mar 2014
 

Abstract

Context: Ceramide causes endothelial apoptosis and emphysema-like changes in animal models.

Objectives: Test if plasma sphingomyelin, a major precursor of ceramide, would predict longitudinal increase in the percentage of emphysema-like lung on computed tomography (CT).

Materials and methods: 3840 participants had their plasma sphingomyelin measured at baseline examination and their pulmonary emphysema measured on cardiac CT scans at baseline and on follow-up visits. Mixed effects models were used to adjust for potential confounders.

Results: One standard deviation increase in sphingomyelin predicted a 0.12% per year (95% CI: 0.02–0.22; p = 0.019) greater increase of percent emphysema.

Discussion and conclusion: Higher plasma levels of sphingomyelin predicted greater annual increase in quantitatively measured percent emphysema.

Acknowledgements

Special thanks also are directed to Jaime Madrigano, BE, MPH, ScD (Research Scientist, Earth Institute, Columbia University) for creating the graph of the outside air density by different scanners over the follow up time.

Supplementary material available online

Tables S1–S5 and Figure S1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.